StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Monthly Share Repurchases (Item 2(c) / Item 5) by Month

Monthly Share Repurchases (Item 2(c) / Item 5) — Total shares purchased in month (thousands)

Vertex Pharmaceuticals Monthly Share Repurchases (Item 2(c) / Item 5): 292.00K in Jun 2026, down 4.9% from a year earlier.

Latest, Jun 2026
292.00
Period ended Jun 28, 2026
Change on a year earlier
-4.9%
307.10 in Jun 2025
History
76 months
Since Oct 2015
Sources
29
Documents cited below

Where the Jun 2026 figure comes from

“|| June 1, 2026 to June 30 , 2026 | 292,000 | $ 452.37 | 292,000 | $ 2,582,008,580”

Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗

Reported in Form 10-Q Part II Item 2(c) & Form 10-K Item 5.

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMonthly Share Repurchases (Item 2(c) / Item 5) — Total shares purchased in month (thousands)Year on yearSource
Jun 2026Jun 28, 2026292.00-4.9%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
May 2026May 28, 2026366.70+4.7%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Apr 2026Apr 28, 2026375.00+77.3%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Mar 2026Mar 28, 2026274.00+46.9%Form 10-Q (vrtx-20260331.htm, filed 2026-05-05) ↗
Feb 2026Feb 28, 2026210.10-1.4%Form 10-Q (vrtx-20260331.htm, filed 2026-05-05) ↗
Jan 2026Jan 28, 2026257.00-51.8%Form 10-Q (vrtx-20260331.htm, filed 2026-05-05) ↗
Oct 2025Oct 28, 2025256.80+11.7%Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
Sep 2025Sep 28, 20251,248.40+524.2%Form 10-Q (vrtx-20250930.htm, filed 2025-11-04) ↗
Aug 2025Aug 28, 20251,221.80+455.4%Form 10-Q (vrtx-20250930.htm, filed 2025-11-04) ↗
Jul 2025Jul 28, 2025258.00+17.3%Form 10-Q (vrtx-20250930.htm, filed 2025-11-04) ↗
Jun 2025Jun 28, 2025307.10+61.6%Form 10-Q (vrtx-20250630.htm, filed 2025-08-05) ↗
May 2025May 28, 2025350.10+45.9%Form 10-Q (vrtx-20250630.htm, filed 2025-08-05) ↗
Apr 2025Apr 28, 2025211.50-30.9%Form 10-Q (vrtx-20250630.htm, filed 2025-08-05) ↗
Mar 2025Mar 28, 2025186.50-22.9%Form 10-Q (vrtx-20250331.htm, filed 2025-05-06) ↗
Feb 2025Feb 28, 2025213.00+126.6%Form 10-Q (vrtx-20250331.htm, filed 2025-05-06) ↗
Jan 2025Jan 28, 2025533.00–Form 10-Q (vrtx-20250331.htm, filed 2025-05-06) ↗

Breakdown

What makes up monthly Share Repurchases (Item 2(c) / Item 5)

Cite this data

StockData. (2026). Vertex Pharmaceuticals Monthly Share Repurchases (Item 2(c) / Item 5), monthly Oct 2015–Jun 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/monthly-buyback-sh

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.